Achillion Pharmaceuticals Gears Up for Secondary Offering
Achillion Pharmaceuticals saw its shares make a handy gain on Thursday after the company announced a secondary offering.
All Work
Chris Lange
L Brands Just Can’t Seem to Win With Earnings
L Brands shares pulled back after the company reported its most recent quarterly results late on Thursday.
Best Buy Offers Disappointing Holiday Quarter Outlook
Best Buy reported inline fiscal third-quarter financial results before the markets opened on Thursday, but shares retreated.
Is Cisco Finally Back After Q1 Earnings?
Cisco Systems, Inc. (NASDAQ: CSCO) reported its fiscal first-quarter financial results after the markets closed on Wednesday. The company said that it had $0.61 in earnings per share (EPS) and $12.1 billion in revenue,…
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was another down day for all the U.S. broad markets. Crude oil responded in kind and was down on the day as well. The S&P 500 sectors were almost entirely negative with one…
What to Watch in Walmart’s Earnings
The holiday season is now upon us, and even though results for the Christmas quarter won’t be seen yet, investors can expect some updated guidance from Walmart and how it plans to fight Amazon…
Amazon Cuts Whole Foods Prices Again Ahead of Holidays
Amazon.com is back at it again, slashing its prices. The e-commerce empire announced that it will cut prices on holiday staples and other groceries at its recently acquired organic grocer, Whole Foods.
CarGurus Races to New High on Strong Q3 Results
CarGurus saw its shares hit a new high on Wednesday following the announcement of its most recent quarterly results.
What to Expect From Cisco Earnings After the Close
Cisco seems to be at a fork in the road with this earnings report. On one hand a strong showing could see a major breakout for shares, while a loss might reveal that Cisco…
GE Market Cap Drops Below Mastercard
General Electric is continuing its fall from grace after earlier this week announcing that it would be cutting its dividend and making some changes to its business model.
Acorda Therapeutics Gets Crushed After Halting Parkinson’s Trial
Acorda Therapeutics saw its shares drop sharply following an announcement that it had paused new enrollment in a long-term safety study. In a sense, Acorda has halted this trial.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a down day for all the major U.S. exchanges. Crude oil responded in kind and was down on the day as well. The S&P 500 sectors were mostly negative with a few…
Loxo Loses Out Despite Signing Big Cancer Deal
Loxo Oncology has announced that it will be partnering with Bayer to develop and commercialize larotrectinib and LOXO-195. Investors seem to believe that Loxo would have been better on its own. At least that’s…
Why Advance Auto Parts Is Tuesday’s Biggest Earnings Winner
When Advance Auto Parts reported its third-quarter financial results before the markets opened on Tuesday, they were mixed. Yet, it seems that this auto parts chain might be making a comeback after a disastrous…
What to Expect When Target Reports Earnings
Target is scheduled to release its most recent quarterly results before the markets open on Wednesday.
GE Market Cap Now Less Than Toyota
GE was a big loser on Monday after it announced that it would be scaling back its dividend and making some changes to its business model.
Jeld-Wen Gears Up for Secondary Offering
Door and window maker Jeld-Wen has filed for a secondary offering, though the company itself is not offering any shares.
Why Stratasys Q3 Earnings Were Good Enough
Stratasys reported mixed quarterly results before the markets opened on Tuesday, but shares were higher in the premarket.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a flat day for the broad U.S. markets. Although the major exchanges started out they day negative, they ended on a slightly positive note. Crude oil took a cue from these and…
Why Argus Is Taking a Step Back on Gilead Sciences
Gilead Sciences, Inc. (NASDAQ: GILD) saw its shares take a step back on Monday after an independent research firm downgraded the stock. Many investors have been hoping that the shares will pull out of…